Markets: News  

Go global in the hunt for dividend yield

Don't miss these top money and investing features:

Go global in hunt for higher dividend yield

What eclipsing the 50-day average means

Positive market outlook for the rest of 2012

Chuck Jaffe writes this week that if you're looking for uncluttered investment pastures, look to Europe and emerging markets. He notes that the herd has been scared off and is instead embracing dividend-paying U.S. stocks. While that is clearly a comfortable move, he says, investors may find their best chance to increase yield and returns--and to buy high-quality assets cheap--comes from going against the herd and owning dividend-focused international-stock mutual funds and exchange-traded funds.

Also in MarketWatch's investment news this week, read Mark Hulbert's column on what it means to eclipse the 50-day average, and a column from Robert Powell on what equity strategists are saying in their midyear updates.

-- , Managing Editor

INVESTING NEWS & TRENDS

Go global in hunt for higher dividend yield

Investors may find their best chance to increase yield and returns--and to buy high-quality assets cheap--comes from dividend-focused international-stock mutual funds and exchange-traded funds, writes Chuck Jaffe.Read more: Go global in hunt for higher dividend yield.

What eclipsing the 50-average means

The Dow's recent close above its 50-day moving average provides me with the occasion to rain on yet another parade--this time that of the bulls.Read more: What eclipsing the 50-day average means.

Positive market outlook for rest of 2012

Equity strategists say that investors are likely to see more volatility in the second half of 2012 than they have in the past six months, but that overall the outlook for U.S. stocks is positive through the end of the year.Read more: Positive market outlook for the rest of 2012.

Next clash for health-care stocks already in sight

Cost-cutting efforts in medicine are locked into place, regardless of how the Supreme Court rules on the nation's 2010 health-care overhaul, and that's likely to put pressure on device makers, analysts say.Read more: Next clash for health-care stocks already in sight.

Bet on Oracle over J.P. Morgan Chase

Buybacks are back in the news. But are they as reliable a signal of outperformance as they used to be?Read more: Bet on Oracle over J.P. Morgan Chase.